Nakao Atsushi, Kawakubo Hirofumi, Takeuchi Masashi, Matsuda Satoru, Fukuda Kazumasa, Kitagawa Yuko
Department of Surgery Keio University School of Medicine Tokyo Japan.
Ann Gastroenterol Surg. 2025 Mar 3;9(3):456-463. doi: 10.1002/ags3.12907. eCollection 2025 May.
Endoscopic laryngopharyngeal surgery is an effective treatment for superficial laryngopharyngeal cancer, particularly in cases with prior esophageal cancer treatment. Despite its frequent application, reports on the risk factors for postoperative complications are limited. This study aimed to identify the risk factors for pneumonia after endoscopic laryngopharyngeal surgery and to examine the variations in pneumonia incidence among the types of prior esophageal cancer treatment.
Patients who had a history of esophageal cancer treatment and subsequently underwent endoscopic laryngopharyngeal surgery for superficial pharyngolaryngeal cancer were retrospectively analyzed. We examined the association between postoperative pneumonia and several factors, including number of lesions; diameter of the resected lesion; and type of previous esophageal cancer treatment, such as endoscopic submucosal dissection, chemoradiotherapy, and esophagectomy.
The study included 79 patients who had a mean age of 67.4 years. Postoperative pneumonia occurred in 16.4%. Multivariate analysis showed that the pneumonia incidence significantly increased in cases with multiple lesions (OR 4.794, 95% CI 1.133-20.288, = 0.033) and larger diameter of the resected lesion (OR 7.047, 95% CI 1.791-27.730, = 0.005). Importantly, compared with other treatments, prior esophagectomy for esophageal cancer did not increase the pneumonia incidence.
Multiple lesions and larger lesion diameter were the significant predictors of postoperative pneumonia. Moreover, endoscopic laryngopharyngeal surgery can be safely performed even in patients who have previously undergone esophageal cancer surgery, although careful monitoring remains necessary.
内镜下咽手术是治疗下咽浅表癌的有效方法,尤其是对于既往接受过食管癌治疗的患者。尽管该手术应用频繁,但关于术后并发症危险因素的报道有限。本研究旨在确定内镜下咽手术后肺炎的危险因素,并探讨既往食管癌治疗类型之间肺炎发生率的差异。
回顾性分析有食管癌治疗史且随后因下咽浅表癌接受内镜下咽手术的患者。我们研究了术后肺炎与几个因素之间的关联,包括病变数量、切除病变的直径,以及既往食管癌治疗的类型,如内镜黏膜下剥离术、放化疗和食管切除术。
该研究纳入了79例患者,平均年龄为67.4岁。术后肺炎发生率为16.4%。多因素分析显示,病变数量多(比值比4.794,95%可信区间1.133 - 20.288,P = 0.033)和切除病变直径较大(比值比7.047,95%可信区间1.791 - 27.730,P = 0.005)的患者肺炎发生率显著增加。重要的是,与其他治疗相比,既往因食管癌行食管切除术并未增加肺炎发生率。
病变数量多和病变直径大是术后肺炎的重要预测因素。此外,即使是既往接受过食管癌手术的患者,内镜下咽手术也可安全进行,尽管仍需仔细监测。